# Investigation Of Receptivity Markers For Endometrial Cancer Treatment Development

> **NCT05914844** · — · COMPLETED · sponsor: **Celal Bayar University** · enrollment: 30 (actual)

## Conditions studied

- Endometrial Cancer Stage

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05914844
- **Lead sponsor:** Celal Bayar University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-19
- **Primary completion:** 2022-08-17
- **Final completion:** 2023-02-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05914844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05914844, "Investigation Of Receptivity Markers For Endometrial Cancer Treatment Development". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05914844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*